2014
DOI: 10.26719/2014.20.1.17
|View full text |Cite
|
Sign up to set email alerts
|

Expanding the comprehensive national neonatal screening programme in the United Arab Emirates from 1995 to 2011

Abstract: The national neonatal screening programme in the United Arab Emirates currently includes 16 disorders: congenital hypothyroidism, sickle-cell diseases, congenital adrenal hyperplasia, biotinidase deficiency and 12 amino acid, organic acid and fatty acid disorders. This paper reports data since the programme started in January 1995 up to December 2011 on the incidence of screened disorders and the molecular basis of positive screened cases. Screening used a combination of tandem mass spectrometry, molecular tec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
38
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(43 citation statements)
references
References 20 publications
4
38
1
Order By: Relevance
“…Data from another large screening program in Lebanon report a prevalence of 1: 1,700 [27]. These rates are comparable to those reported from the United Arab Emirates (1: 1,873) [28], and from the Greek Cypriot population (1: 1,800) [29] but higher than some of the reported rates from Turkey (1: 2,326) [22], Egypt (1: 3,587) [23], and from different regions in Saudi Arabia (1: 2,759 [24] and 1: 4,208 [25]). Nevertheless, this apparently higher rate in the overall incidence of congenital hypothyroidism in Lebanon does not explain the magnitude of the increase in the rates detected in our population of VLBW infants.…”
Section: Discussionsupporting
confidence: 73%
“…Data from another large screening program in Lebanon report a prevalence of 1: 1,700 [27]. These rates are comparable to those reported from the United Arab Emirates (1: 1,873) [28], and from the Greek Cypriot population (1: 1,800) [29] but higher than some of the reported rates from Turkey (1: 2,326) [22], Egypt (1: 3,587) [23], and from different regions in Saudi Arabia (1: 2,759 [24] and 1: 4,208 [25]). Nevertheless, this apparently higher rate in the overall incidence of congenital hypothyroidism in Lebanon does not explain the magnitude of the increase in the rates detected in our population of VLBW infants.…”
Section: Discussionsupporting
confidence: 73%
“…The same disorders of hormone synthesis seem to explain the moderately severe nature of the delayed milestones observed in our study, although the other clinical signs were typical for hypothyroidism (1-3, 5, 22 This trend of a higher incidence of dyshormonogenesis is found in Middle East countries (19)(20)(21). Although, we identified no consanguinity among families, the fact that patients belonged to very closed families, particularly from the same village, might suggest the presence of similar genetic characteristics and explain the predominance of dyshormonosynthesis in our study population (1)(2)(3)20).…”
Section: Discussioncontrasting
confidence: 40%
“…114,115 Likewise, successful screening models in Lebanon and Qatar have demonstrated the feasibility of using screening laboratories in other countries to provide NBS services. 116,117 National NBS programs with extensive screening coverage are now present in Bahrain, Egypt, Iran, Israel, Kuwait, Oman, Qatar (only for Qataris), State of Palestine, Saudi Arabia, and the United Arab Emirates.…”
Section: Middle East and North Africamentioning
confidence: 97%